We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYE icon
1226
iShares US Energy ETF
IYE
$1.8B
$7.62M 0.01%
186,205
-46,774
-20% -$1.72M
IDEV icon
1227
iShares Core MSCI International Developed Markets ETF
IDEV
$32.7B
$7.62M 0.01%
119,694
+700
+0.6% +$45.1K
PLUS icon
1228
ePlus
PLUS
$2.31B
$7.53M 0.01%
134,348
-641
-0.5% -$31.9K
TFLO icon
1229
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
$7.53M 0.01%
149,576
+99,044
+196% +$4.98M
ESGE icon
1230
iShares ESG Aware MSCI EM ETF
ESGE
$6.86B
$7.5M 0.01%
204,213
+14,722
+8% +$565K
XME icon
1231
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
$7.5M 0.01%
122,355
+58,931
+93% +$3M
LNC icon
1232
Lincoln National
LNC
$8.67B
$7.5M 0.01%
114,741
+14,148
+14% +$967K
PNFP icon
1233
Pinnacle Financial Partners Inc
PNFP
$16.2B
$7.5M 0.01%
81,418
+22,877
+39% +$2.26M
DSGX icon
1234
Descartes Systems
DSGX
$6.62B
$7.48M 0.01%
102,095
+1,647
+2% +$119K
NBIX icon
1235
Neurocrine Biosciences
NBIX
$15.3B
$7.48M 0.01%
79,746
+14,089
+21% +$1.19M
ESMT
1236
DELISTED
EngageSmart, Inc.
ESMT
$7.47M 0.01%
350,782
+118,912
+51% +$2.47M
GVI icon
1237
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
$7.45M 0.01%
68,648
+3,323
+5% +$369K
LVS icon
1238
Las Vegas Sands
LVS
$29.6B
$7.45M 0.01%
191,593
-75,762
-28% -$3.14M
GMAB icon
1239
Genmab
GMAB
$19.3B
$7.45M 0.01%
205,815
+34,384
+20% +$1.18M
SAFM
1240
DELISTED
Sanderson Farms Inc
SAFM
$7.43M 0.01%
39,644
-61,154
-61% -$11.2M
CCXI
1241
DELISTED
ChemoCentryx, Inc.
CCXI
$7.39M 0.01%
294,833
+16,995
+6% +$478K
RODM icon
1242
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.65B
$7.38M 0.01%
253,533
-88,219
-26% -$2.58M
QQQE icon
1243
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.45B
$7.34M 0.01%
94,951
+127
+0.1% +$9.71K
MRCY icon
1244
Mercury Systems
MRCY
$6.59B
$7.34M 0.01%
113,856
-11,456
-9% -$680K
EDV icon
1245
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
$7.31M 0.01%
60,080
+10,130
+20% +$1.3M
MGY icon
1246
Magnolia Oil & Gas
MGY
$6.13B
$7.26M 0.01%
307,192
+99,512
+48% +$2.18M
LSTR icon
1247
Landstar System
LSTR
$6.4B
$7.26M 0.01%
48,122
-94,739
-66% -$15.1M
OLPX
1248
DELISTED
Olaplex Holdings
OLPX
$7.25M 0.01%
464,066
+232,177
+100% +$4.43M
MFC icon
1249
Manulife Financial
MFC
$72.9B
$7.25M 0.01%
339,469
+13,724
+4% +$281K
SLY
1250
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$7.24M 0.01%
77,323
+11,404
+17% +$1.07M

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.